Deep brain stimulation in parkinsonian patients with dopa intolerance
Neurocirugia (Astur : Engl Ed). 2018 Jul-Aug;29(4):213-215.
doi: 10.1016/j.neucir.2017.09.005.
Epub 2017 Oct 28.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neurología, Fundación Jiménez Díaz, Madrid, España.
- 2 Servicio de Neurología, Fundación Jiménez Díaz, Madrid, España. Electronic address: cefeliz@fjd.es.
- 3 Servicio de Neurocirugía, Fundación Jiménez Díaz, Madrid, España.
- 4 Servicio de Neurología, Hospital Universitario Insular, Las Palmas de Gran Canaria, España.
- 5 Servicio de Neurología, Hospital Universitario Central de Asturias, Oviedo, España.
Abstract
Deep brain stimulation (DBS) is at present, a useful treatment for patients with advanced Parkinson's disease and motor complications. The crucial step toward consistent DBS outcomes remains careful patient selection; several conditions must be fulfilled including excellent levo dopa response. We report two cases of early onset Parkinson's disease with severe intolerance to levo dopa but excellent and sustained response to DBS. DBS can be a useful alternative for parkinsonian patients with severe intolerance to levo dopa, provided a positive acute response to levo dopa or apomorphine is obtained.
Keywords:
Deep brain stimulat; Enfermedad de Parkinson; Estimulación cerebral profunda; Intolerancia a levodopa; Levodopa intolerance; Parkinson's disease.
Copyright © 2017 Sociedad Española de Neurocirugía. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Antiparkinson Agents / adverse effects
-
Deep Brain Stimulation*
-
Female
-
Humans
-
Levodopa / adverse effects
-
Middle Aged
-
Parkinson Disease / drug therapy
-
Parkinson Disease / therapy*
Substances
-
Antiparkinson Agents
-
Levodopa